Skip to content skip to primary navi skip to secondary navi skip to meta navi search

Trial overview

With its clinical trials the GHSG aims to further optimize the first-line treatment for patients with all stages of Hodgkin lymphoma and to improve therapy for relapsed patients by reducing treatment-related adverse effects while maintaining the efficacy of treatment. Please click here for an overview of the GHSG’s ongoing trials.